Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 46, Issue 6, Pages 2193-2205Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2011.02.073
Keywords
Acetylcholinesterase inhibitors; N-3-Isobutyrylcycloxobuxidine-F derivatives; Molecular modeling; Alzheimer's disease; beta-amyloid aggregation; Butyrylcholinesterase; Synthesis
Categories
Funding
- CNRS
- ICSN
- Institut de Chimie des Substances Naturelles (ICSN-CNRS)
Ask authors/readers for more resources
New acetylcholinesterase inhibitors in the tetracyclic triterpene series were synthesized, tested in vitro for the inhibition of cholinesterases (different sources of AChE and BuChE) and for the ability to prevent AChE-induced A beta aggregation. Some compounds have hAChE IC50 values in the nanomolar range and showed ability to block the AChE-induced A beta aggregation. The mode of interaction between EeAChE and compounds 1 and 36e was investigated using docking and molecular dynamics simulations. These studies suggested that both compounds interact simultaneously with the catalytic and the peripheral sites of AChE, and the nature of protein-ligand interactions is mainly hydrophobic. (C) 2011 Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available